H Olsson|A Borg - JoVE Visualize

Showing results (1-10 of 710) with videos related to

Pageof 71

Sort By:

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 1, 1997

Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patientsH C Jernström, H Olsson, A Borg

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern SwedenO T Jóhannsson, J Ranstam, A Borg, et al.

Genes, Chromosomes & Cancer|November 1, 1992

Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosisA Borg, Q X Zhang, H Olsson, et al.

Journal of the National Cancer Institute|August 16, 2001

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancerN Loman, O Johannsson, U Kristoffersson, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006

Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer familiesH Jernström, T Sandberg, E Bågeman, et al.

Molecular Human Reproduction|February 20, 2007

CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy womenM Henningson, U Johansson, A Borg, et al.

Human Reproduction (Oxford, England)|August 22, 2006

Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young womenM Hietala, T Sandberg, A Borg, et al.

Journal of the National Cancer Institute|October 16, 1991

Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormonesH Olsson, A Borg, M Fernö, et al.

Genes, Chromosomes & Cancer|August 5, 2000

Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutationM Planck, E Wenngren, A Borg, et al.

British Journal of Cancer|March 10, 2005

Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer familiesH Jernström, T Sandberg, E Bågeman, et al.

Pageof 71

Showing results (1-10 of 710) with videos related to

Sort By:

Pageof 71

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 1, 1997

Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patientsH C Jernström, H Olsson, A Borg

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern SwedenO T Jóhannsson, J Ranstam, A Borg, et al.

Genes, Chromosomes & Cancer|November 1, 1992

Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosisA Borg, Q X Zhang, H Olsson, et al.

Journal of the National Cancer Institute|August 16, 2001

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancerN Loman, O Johannsson, U Kristoffersson, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006

Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer familiesH Jernström, T Sandberg, E Bågeman, et al.

Molecular Human Reproduction|February 20, 2007

CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy womenM Henningson, U Johansson, A Borg, et al.

Human Reproduction (Oxford, England)|August 22, 2006

Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young womenM Hietala, T Sandberg, A Borg, et al.

Journal of the National Cancer Institute|October 16, 1991

Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormonesH Olsson, A Borg, M Fernö, et al.

Genes, Chromosomes & Cancer|August 5, 2000

Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutationM Planck, E Wenngren, A Borg, et al.

British Journal of Cancer|March 10, 2005

Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer familiesH Jernström, T Sandberg, E Bågeman, et al.

Pageof 71